Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) just unveiled an update.
Recordati has disclosed transactions involving the sale and purchase of treasury shares. The company sold treasury shares directly to beneficiaries of its stock option plans and executed a share buy-back program through UBS Europe SE, which concluded on March 31, 2025. These transactions are part of Recordati’s strategic financial management, potentially impacting its stock liquidity and shareholder value.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati Industria Chimica e Farmaceutica SPA is a pharmaceutical company based in Italy, primarily engaged in the development, manufacturing, and marketing of pharmaceuticals. The company focuses on treatments for rare diseases and specialty care, serving a global market.
YTD Price Performance: 2.17%
Average Trading Volume: 33,285
Technical Sentiment Signal: Sell
Current Market Cap: €10.91B
For detailed information about REC stock, go to TipRanks’ Stock Analysis page.